A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Minerva Neurosciences, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 167,700 shares of NERV stock, worth $389,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares
167,700
Previous 177,765 5.66%
Holding current value
$389,064
Previous $459,000 16.34%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$2.33 - $3.65 $23,451 - $36,737
-10,065 Reduced 5.66%
167,700 $534,000
Q1 2024

May 13, 2024

BUY
$2.5 - $12.47 $176,412 - $879,945
70,565 Added 65.83%
177,765 $459,000
Q4 2023

Feb 13, 2024

BUY
$3.96 - $7.85 $51,480 - $102,050
13,000 Added 13.8%
107,200 $659,000
Q3 2023

Nov 14, 2023

SELL
$6.9 - $13.05 $28,290 - $53,505
-4,100 Reduced 4.17%
94,200 $650,000
Q2 2023

Aug 11, 2023

SELL
$1.62 - $10.19 $20,250 - $127,375
-12,500 Reduced 11.28%
98,300 $898,000
Q1 2023

May 12, 2023

BUY
$1.51 - $3.09 $755 - $1,545
500 Added 0.45%
110,800 $177,000
Q4 2022

Feb 13, 2023

BUY
$1.43 - $13.43 $12,155 - $114,155
8,500 Added 8.35%
110,300 $175,000
Q3 2022

Nov 14, 2022

BUY
$2.53 - $13.17 $167,458 - $871,709
66,189 Added 185.87%
101,800 $940,000
Q2 2022

Aug 12, 2022

BUY
$2.7 - $7.68 $96,149 - $273,492
35,611 New
35,611 $118,000

Others Institutions Holding NERV

About Minerva Neurosciences, Inc.


  • Ticker NERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,340,190
  • Market Cap $12.4M
  • Description
  • Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...
More about NERV
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.